DNMT polymorphisms are associated with PCa progression by means of downregulatory tumor suppressor gene promoter methylation [64] and elevated DNMT3B expression in aggressive versus non-aggressive PCa cell lines [65]. The gene discussed is DNMT3B; the disease is posterior cortical atrophy.